From Barchart:

Weight-loss drugs sales are projected to exceed $100 billion by 2030, according to J.P. Morgan. This is good news for Eli Lilly, currently the largest pharma company by market capitalization and the 9th-biggest S&P 500 stock. LLY stock looks set to grow even more in the months ahead.



Read more: It’s Not Too Late to Buy Eli Lilly Stock. Here’s Why.